Key facts
- It has raised $4.0M; the latest was Later Stage VC in Apr 2026.
- Notable investors include Aceleradora Litoral, Bio.r, Innventure AgriFood Tech, Ministry of Science, Technology and Productive Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for BioHeuris
- ·The full record, as it builds
Funding rounds
No funding rounds for BioHeuris are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioHeuris
Developer of gene-edited traits designed to enhance weed management in crops. The company offers CRISPR-based technologies, protein-directed evolution, and precision breeding to introduce herbicide tolerance in crops like sorghum and rice, enabling farmers to use a wider range of low-dose herbicides while reducing development time and regulatory costs.
- Sector
- Materials and Resources
- HQ
- Rosario, Argentina
- Founded
- 2016
- Employees
- 16
- Website
- bioheuris.com/
- Ownership
- Privately Held (backing)
BioHeuris doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioHeuris shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioHeuris in its N-PORT filings yet. We sweep new filings monthly.